drugset / Trial / NCT06463678
Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis
RandomizedParallel-groupTriple-blindTreatment
Summary
A Phase II, Multi-center, Randomized, Masked, Parallel-Control Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution in the Treatment of Fungal Keratitis.
Timeline
- Start
- 2026-08-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IVIEW-1201 | Unknown | 1 % | Other |
| Subject | IVIEW-1201 | Unknown | 1 unknown | Other |
| Comparator | Natamycin | Small molecule | 1 unknown | Other |